vedolizumab

Takeda’s Vedolizumab Clears Phase III in aGvHD
BioSpace
Tue, 02/21/23 - 10:03 am
Takeda
vedolizumab
graft vs host disease
clinical trials
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
CP Wire
Thu, 07/19/18 - 11:20 am
Takeda
vedolizumab
ulcerative colitis
Entyvio
A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests
Stat
Fri, 10/14/16 - 11:42 am
Crohn’s disease
HIV
vedolizumab
Entyvio
Takeda
Takeda’s Bowel Disease Drug Approved by U.S. Regulators
Bloomberg
Wed, 05/21/14 - 10:26 am
Takeda
FDA
Entyvio
vedolizumab
ulcerative colitis
Crohn's Disease
Takeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease
The Pharma Letter
Sat, 03/22/14 - 12:46 pm
Takeda
vedolizumab
Entyvio
ulcerative colitis
Crohn's Disease
Takeda Drug for Bowel Diseases Wins U.S. Panel's Backing
Bloomberg
Tue, 12/10/13 - 09:18 am
Takeda
FDA
advisory panels
vedolizumab
Takeda’s Experimental Bowel Drug Shown Effective, Studies Find
Bloomberg/Businessweek
Thu, 08/22/13 - 10:10 am
ulcerative colitis
Chron's Disease
Takeda
vedolizumab
Takeda files BLA for vedolizumab for Crohn's and ulcerative colitis in USA
The Pharma Letter
Sat, 06/22/13 - 10:38 am
Takeda
vedolizumab
Chron's Disease
ulcerative colitis